http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110859997-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-254 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-32 |
| filingDate | 2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110859997-B |
| titleOfInvention | Dental implant with osteogenesis-anti-inflammatory-blood sugar three-dimensional response structure and preparation method thereof |
| abstract | The invention provides a dental implant with an osteogenesis-anti-inflammatory-blood sugar three-dimensional response structure, which consists of a dental implant and a drug controlled release system with an osteogenesis-anti-inflammatory-blood sugar three-dimensional response structure, wherein the drug controlled release system consists of an osteogenesis layer, an anti-inflammatory layer and a blood sugar sensing layer, the osteogenesis layer consists of chitosan hydrogel and nano hydroxyapatite dispersed in the chitosan hydrogel, the anti-inflammatory layer consists of cross-linked quaternized chitosan hydrogel and anti-inflammatory substances and glucose oxidase dispersed in the chitosan hydrogel, and the blood sugar sensing layer is a coating consisting of glucose oxidase; the surface of the dental implant is provided with a nano-pore structure, an osteogenesis layer of a drug controlled release system is filled in the nano-pore structure of the dental implant and coats the dental implant, an anti-inflammatory layer coats the osteogenesis layer, and a blood sugar sensing layer coats the anti-inflammatory layer. The dental implant can promote osseointegration under the hyperglycemia state, provides a new anti-inflammatory treatment technology for the dental implant patients with diabetes, and can meet the clinical requirements of dental implant repair of the dental implants patients with diabetes. |
| priorityDate | 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 191.